{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T06:11:50Z","timestamp":1762323110275},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2001,2,1]],"date-time":"2001-02-01T00:00:00Z","timestamp":980985600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Gastro"],"published-print":{"date-parts":[[2001,2]]},"DOI":"10.1007\/s11938-001-0044-0","type":"journal-article","created":{"date-parts":[[2007,6,3]],"date-time":"2007-06-03T17:47:33Z","timestamp":1180892853000},"page":"23-38","source":"Crossref","is-referenced-by-count":8,"title":["Foodborne illnesses"],"prefix":"10.1007","volume":"4","author":[{"given":"Christopher J.","family":"Gill","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davidson H.","family":"Hamer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"44_CR1","doi-asserted-by":"crossref","first-page":"607","DOI":"10.3201\/eid0505.990502","volume":"5","author":"PS Mead","year":"1999","unstructured":"Mead PS, Slutsker L, Dietz V, et al.: Food-related illness and death in the United States. Emerg Infect Dis 1999, 5:607\u2013625. This is a massive ecologic report describing the pathogen specific burden of foodborne illness in the United States. It elucidates the assumptions underlying the calculated incidence for each pathogen.","journal-title":"Emerg Infect Dis"},{"key":"44_CR2","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3201\/eid0304.970403","volume":"3","author":"RV Tauxe","year":"1997","unstructured":"Tauxe RV: Emerging foodborne diseases: an evolving public health challenge. Emerg Infect Dis 1997, 3:425\u2013434. A thoughtful discussion of factors underlying recent trends in foodborne infectious disease.","journal-title":"Emerg Infect Dis"},{"key":"44_CR3","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/0140-6736(90)93250-S","volume":"336","author":"E Todd","year":"1990","unstructured":"Todd E: Epidemiology of foodborne illness: North America. Lancet 1990, 336:788\u2013793.","journal-title":"Lancet"},{"key":"44_CR4","first-page":"107","volume":"103","author":"WE Garthwright","year":"1988","unstructured":"Garthwright WE, Archer DL, Kvenberg JE: Estimates of incidence and costs of intestinal infectious disease in the United States. Public Health Rep 1988, 103:107\u2013115.","journal-title":"Public Health Rep"},{"key":"44_CR5","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/0140-6736(90)92213-2","volume":"336","author":"WM Waites","year":"1990","unstructured":"Waites WM, Arbuthnott JP: Foodborne illness: an overview. Lancet 1990, 336:722\u2013725.","journal-title":"Lancet"},{"key":"44_CR6","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1016\/0140-6736(90)93189-V","volume":"336","author":"MRA Morgan","year":"1990","unstructured":"Morgan MRA, Fenwick GR: Foodborne illness\u2014natural foodborne toxicants. Lancet 1990, 336:1492\u20131495.","journal-title":"Lancet"},{"key":"44_CR7","first-page":"237","volume":"22","author":"A Forbes","year":"1988","unstructured":"Forbes A, Williams R: Increasing age\u2014an important adverse prognostic factor in hepatitis A virus infection. J R Coll Physicians Lond 1988, 22:237\u2013239.","journal-title":"J R Coll Physicians Lond"},{"key":"44_CR8","first-page":"55","volume-title":"Travel and routine immunizations\u2014a practical guide for the medical office","author":"RF Thompson","year":"2000","unstructured":"Thompson RF: Travel and routine immunizations\u2014a practical guide for the medical office. 2000 Edition. Milwaukee: Shoreland, Inc; 2000:55\u201361.","edition":"2000 Edition"},{"key":"44_CR9","first-page":"1","volume":"45","author":"Centers for Disease Control and Prevention","year":"1996","unstructured":"Centers for Disease Control and Prevention: Prevention of hepatitis A through active or passive immunization. Recommendations of the advisory committee on immunization practices (ACIP). MMWR Morb Mortal Wkly 1996, 45:1\u201330. Guidelines are provided for the management of hepatitis A exposures. These should be of relevance to specialists and primary care physicians alike.","journal-title":"MMWR Morb Mortal Wkly"},{"key":"44_CR10","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/S0140-6736(98)08139-2","volume":"353","author":"L Sagliocca","year":"1999","unstructured":"Sagliocca L, Amoroso P, Stroffolini T, et al.: Efficacy of hepatitis A vaccine in prevention of secondary hepatitis A infections: a randomized trial. Lancet 1999, 353:1136\u20131139.","journal-title":"Lancet"},{"key":"44_CR11","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0272-2712(18)30105-7","volume":"19","author":"JK Crane","year":"1999","unstructured":"Crane JK: Preformed bacterial toxins. Clin Lab Med 1999, 19:583\u2013599.","journal-title":"Clin Lab Med"},{"key":"44_CR12","doi-asserted-by":"crossref","first-page":"221","DOI":"10.7326\/0003-4819-129-3-199808010-00011","volume":"129","author":"RL Shapiro","year":"1998","unstructured":"Shapiro RL, Hatheway C, Swerdlow DL: Botulism in the United States: a clinical and epidemiologic review. Ann Int Med 1998, 129:221\u2013228. A concise discussion of the pathophysiology, epidemiology and treatment of all forms of botulism.","journal-title":"Ann Int Med"},{"key":"44_CR13","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/0002-9343(84)90988-4","volume":"76","author":"CO Tacket","year":"1984","unstructured":"Tacket CO, Shandera W, Mann J, et al.: Equine antitoxin use and other factors that predict outcome in type A foodborne botulism. Am J Med 1984, 76:794\u2013798.","journal-title":"Am J Med"},{"key":"44_CR14","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/infdis\/150.3.407","volume":"150","author":"CL Hatheway","year":"1984","unstructured":"Hatheway CL, Snyder JD, Seals JE, et al.: Antitoxin levels in botulism patients treated with trivalent equine botulism antitoxin to toxin types A, B, and E. J Infect Dis 1984, 150:407\u2013412.","journal-title":"J Infect Dis"},{"key":"44_CR15","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1086\/513745","volume":"25","author":"YR Ortega","year":"1997","unstructured":"Ortega YR, Adam RD: Giardia. Overview and update. Clin Infect Dis 1997, 25:545\u2013550.","journal-title":"Clin Infect Dis"},{"key":"44_CR16","volume-title":"Cryptosporidium and Cryptosporidiosis","author":"BL Blagburn","year":"1997","unstructured":"Blagburn BL, Soave R: Prophylaxis and chemotherapy: human and animal. In Cryptosporidium and Cryptosporidiosis. Edited by Fayer R. Boca Raton: CRC Press; 1997."},{"key":"44_CR17","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S0002-9343(97)89499-5","volume":"100","author":"TP Flanigan","year":"1996","unstructured":"Flanigan TP, Ramratnam B, Graeber C, et al.: Prospective trial of paromomycin for cryptosporidiosis in AIDS. Am J Med 1996, 100:370\u2013372.","journal-title":"Am J Med"},{"key":"44_CR18","unstructured":"Hewitt RG, Yiannoutsoss CT, Carey J, et al.: A doubleblind, placebo-controlled trial of paromomycin (par) for the treatment of cryptosporidiosis (cs) in patients with advanced HIV disease and CD4 counts under 150 (ACTG 192) [abstract]. In Washington, DC, 4th Conference on Retroviruses and Opportunistic Infections, January 22\u201326, 1997."},{"key":"44_CR19","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/00002030-199801000-00005","volume":"12","author":"NA Foudraine","year":"1998","unstructured":"Foudraine NA, Weverling GJ, van Gool T, et al.: Improvement of chronic diarrhoea in patients with advanced HIV-1 infection during potent antiretroviral therapy. AIDS 1998, 12:35\u201341.","journal-title":"AIDS"},{"key":"44_CR20","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S0035-9203(98)90804-5","volume":"92","author":"JF Rossignon","year":"1998","unstructured":"Rossignon JF, Hidalgo H, Feregrion M, et al.: A double-\"blind\" placebo-controlled study of nitazoxanide in the treatment of cryptosporidial diarrhoea in AIDS patients in Mexico. Trans R Soc Trop Med Hyg 1998, 92:663\u2013666.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"44_CR21","doi-asserted-by":"crossref","first-page":"885","DOI":"10.7326\/0003-4819-132-11-200006060-00006","volume":"132","author":"RI Verdier","year":"2000","unstructured":"Verdier RI, Fitzgerald DW, Johnson WE Jr, Pape JW: Trimethoprim-sulfamethoxazole compared with ciprofloxacin for treatment and prophylaxis of Isospora belli and Cyclospora cayetanensis infection in HIV-infected patients\u2014a randomized controlled trial. Ann Int Med 2000, 132:885\u2013888.","journal-title":"Ann Int Med"},{"key":"44_CR22","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1093\/infdis\/166.6.1429","volume":"166","author":"AA Ries","year":"1992","unstructured":"Ries AA, Vugia DJ, Beingolea L, et al.: Cholera in Piura, Peru: a modern urban epidemic. J Infect Dis 1992, 166:1429\u20131433.","journal-title":"J Infect Dis"},{"key":"44_CR23","first-page":"562","volume":"40","author":"Centers for Disease Control and Prevention","year":"1991","unstructured":"Centers for Disease Control and Prevention: Update: cholera\u2014western hemisphere, and recommendations for treatment of cholera. MMWR Morb Mortal Wkly 1991, 40:562\u2013565.","journal-title":"MMWR Morb Mortal Wkly"},{"key":"44_CR24","volume-title":"The quinolones","author":"DH Hamer","year":"2000","unstructured":"Hamer DH, Gorbach SL: Use of the quinolones for the treatment of and prophylaxis of bacterial infections. In The quinolones, edn 3. Edited by Andriole VT. San Diego: Academic Press; 2000.","edition":"edn 3"},{"key":"44_CR25","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0140-6736(96)01180-4","volume":"348","author":"WA Khan","year":"1996","unstructured":"Khan WA, Bennish ML, Seas C, et al.: A randomized controlled comparison of single-dose ciprofloxacin and doxycycline for cholera caused by Vibrio cholerae O1 or O139. Lancet 1996, 348:296\u2013300.","journal-title":"Lancet"},{"key":"44_CR26","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S0196-0644(99)70174-5","volume":"34","author":"CV Pollack","year":"1999","unstructured":"Pollack CV, Fuller J: Outbreak of Vibrio parahaemolyticus infection associated with eating raw oysters and clams harvested from Long Island Sound-Connecticut, New Jersey, and New York, 1998. Ann Emerg Med 1999, 34:679\u2013680.","journal-title":"Ann Emerg Med"},{"key":"44_CR27","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1093\/jac\/13.2.171","volume":"13","author":"C Uylangco","year":"1984","unstructured":"Uylangco C, Santiago L, Pescanted M, et al.: Pivmecillinam, co-trimoxazole and oral mecillinam in gastroenteritis due to Vibrio spp. J Antimicrobial Chemo 1984, 13:171\u2013175.","journal-title":"J Antimicrobial Chemo"},{"key":"44_CR28","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1086\/313715","volume":"30","author":"ML Replogle","year":"2000","unstructured":"Replogle ML, Fleming DW, Cieslak PR: Emergence of antimicrobial-resistant shigellosis in Oregon. Clin Infect Dis 2000, 30:515\u2013519.","journal-title":"Clin Infect Dis"},{"issue":"Suppl 4","key":"44_CR29","doi-asserted-by":"crossref","first-page":"S332","DOI":"10.1093\/clinids\/13.Supplement_4.S332","volume":"13","author":"MA Salam","year":"1991","unstructured":"Salam MA, Bennish ML: Antimicrobial therapy for shigellosis. Rev Infect Dis 1991, 13(Suppl 4):S332\u2013341. This review considers treatment options for shigellosis in the United States and in developing nations given changes in antibiotic susceptibility patterns.","journal-title":"Rev Infect Dis"},{"key":"44_CR30","doi-asserted-by":"crossref","first-page":"697","DOI":"10.7326\/0003-4819-126-9-199705010-00004","volume":"126","author":"WA Khan","year":"1997","unstructured":"Khan WA, Seas C, Dhar U, et al.: Treatment of shigellosis: V. Comparison of azithromycin and ciprofloxacin. A double-blind, randomized, controlled trial. Ann Int Med 1997, 126:697\u2013703.","journal-title":"Ann Int Med"},{"key":"44_CR31","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1056\/NEJM199306243282507","volume":"328","author":"HL DuPont","year":"1993","unstructured":"DuPont HL, Ericcson CD: Prevention and treatment of traveler\u2019s diarrhea. N Engl J Med 1993, 328:1821\u20131827. This article summarizes various epidemiologic and therapeutic aspects of traveller\u2019s diarrhea.","journal-title":"N Engl J Med"},{"key":"44_CR32","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1056\/NEJM199508103330608","volume":"336","author":"TG Boyce","year":"1995","unstructured":"Boyce TG, Swerdlow DL, Griffin PM: Escherichia coli O157:H7 and the hemolytic-uremic syndrome. N Engl J Med 1995, 336:364\u2013368. A detailed topic review of EHEC and HUS.","journal-title":"N Engl J Med"},{"key":"44_CR33","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1086\/315239","volume":"181","author":"X Zhang","year":"2000","unstructured":"Zhang X, McDaniel AD, Wolf LE, et al.: Quinolone antibiotics induce Shiga toxin-encoding bacteriophages, toxin production, and death in mice. J Infect Dis 2000, 181:664\u2013670.","journal-title":"J Infect Dis"},{"key":"44_CR34","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1056\/NEJM200006293422601","volume":"342","author":"CS Wong","year":"2000","unstructured":"Wong CS, Srdjan J, Habeeb RL, et al.: The risk of hemolytic uremic infections. N Engl J Med 2000, 342:1930\u20131936. An important case control study suggesting an increased risk of HUS due to antibiotic therapy.","journal-title":"N Engl J Med"},{"key":"44_CR35","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0140-6736(82)90380-4","volume":"1","author":"BJ Anders","year":"1982","unstructured":"Anders BJ, Lauer BA, Paisley JW, Reller LB: Double-blind placebo controlled trial of erythromycin for treatment of Campylobacter enteritis. Lancet 1982, 1:131\u2013132.","journal-title":"Lancet"},{"key":"44_CR36","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1056\/NEJM199905203402001","volume":"340","author":"KE Smith","year":"1999","unstructured":"Smith KE, Besser JM, Hedberg CW, et al.: Quinoloneresistant Campylobacter jejuni infections in Minnesota, 1992\u20131998. N Engl J Med 1999, 340:1525\u20131532.","journal-title":"N Engl J Med"},{"key":"44_CR37","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1086\/515248","volume":"177","author":"PA Meier","year":"1998","unstructured":"Meier PA, Dooley DP, Jorgensen JH, et al.: Development of quinolone-resistant Campylobacter fetus bacteremia in Human Immunodeficiency Virus-infected patients. J Infect Dis 1998, 177:951\u2013954.","journal-title":"J Infect Dis"},{"key":"44_CR38","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1001\/jama.283.20.2668","volume":"283","author":"ML Ackers","year":"2000","unstructured":"Ackers ML, Puhr ND, Tauxe RV, Mintz ED: Laboratorybased surveillance of Salmonella serotype Typhi infections in the Unites States: antimicrobial resistance on the rise. JAMA 2000, 283:2668\u20132673.","journal-title":"JAMA"},{"key":"44_CR39","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1128\/AAC.44.7.1855-1859.2000","volume":"44","author":"NT Chinh","year":"2000","unstructured":"Chinh NT, Parry CM, Ly NT, et al.: A randomized controlled comparison of azithromycin and ofloxacin for treatment of multidrug-resistant or nalidixic acidresistant enteric fever. Antimicrob Agents Chemother 2000, 44:1855\u20131859.","journal-title":"Antimicrob Agents Chemother"},{"key":"44_CR40","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1093\/clinids\/9.4.719","volume":"9","author":"GB Soe","year":"1987","unstructured":"Soe GB, Overturf GD: Treatment of typhoid fever and other systemic salmonelloses with Cefotaxime, Ceftriaxone, Cefoperazone, and other newer cephalosporins. Rev Infect Dis 1987, 9:719\u2013736.","journal-title":"Rev Infect Dis"},{"key":"44_CR41","doi-asserted-by":"crossref","first-page":"S1179","DOI":"10.1093\/clinids\/11.Supplement_5.S1179","volume":"11","author":"E Rodruiguez-Noriega","year":"1989","unstructured":"Rodruiguez-Noriega E, Andrade-Villaneuva J, Amaya-Tapia G: Quinolones in the treatment of Salmonella carriers. Rev Infect Dis 1989, 11:S1179\u20131187. This review summarizes the data on fluoroquinolones for nonsurgical treatment of Salmonella carriers.","journal-title":"Rev Infect Dis"},{"key":"44_CR42","doi-asserted-by":"crossref","first-page":"567","DOI":"10.2307\/4592192","volume":"79","author":"JL Freitag","year":"1964","unstructured":"Freitag JL: Treatment of chronic typhoid carriers by cholecystectomy. Public Health Rep 1964, 79:567\u2013570.","journal-title":"Public Health Rep"},{"key":"44_CR43","doi-asserted-by":"crossref","first-page":"189","DOI":"10.7326\/0003-4819-102-2-189","volume":"102","author":"JL Jacobs","year":"1985","unstructured":"Jacobs JL, Gold JW, Murray HW, et al.: Recurrent Salmonella infections in patients with the acquired immunodeficiency syndrome. Ann Int Med 1985, 102:189\u2013183.","journal-title":"Ann Int Med"},{"key":"44_CR44","volume-title":"Antibiotics for treating Salmonella gut infections. The Cochrane Library","author":"S Sirinavin","year":"1999","unstructured":"Sirinavin S, Garner P: Antibiotics for treating Salmonella gut infections. The Cochrane Library, edn 3 [CD-ROM]. Oxford: Update Software; 1999. This meta-analysis of antibiotic trials for uncomplicated salmonellosis supported the traditional teachings that antibiotics are unhelpful and potentially harmful in most NTS infections.","edition":"edn 3"},{"key":"44_CR45","doi-asserted-by":"crossref","first-page":"553","DOI":"10.3109\/00365549009027095","volume":"22","author":"C Goran","year":"1990","unstructured":"Goran C, Dahl P, Niklasson PM, et al.: Norfloxacin treatment of Salmonellosis does not shorten the carrier stage. Scand J Infect Dis 1990, 22:553\u2013556. A well-designed clinical trial attempting to examine the relationship between therapy and the carrier state in NTS. As with previous reports, the carrier state was prolonged by therapy.","journal-title":"Scand J Infect Dis"},{"key":"44_CR46","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1086\/513747","volume":"25","author":"ML Fernandez","year":"1997","unstructured":"Fernandez ML, Ramos JM, Nunez A, et al.: Focal infections due to non-typhi Salmonella in patients with AIDS: report of 10 cases and review. Clin Infect Dis 1997, 25:690\u2013697.","journal-title":"Clin Infect Dis"},{"key":"44_CR47","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S0022-3476(84)81020-3","volume":"104","author":"CH Pai","year":"1984","unstructured":"Pai CH, Gillis F, Tuomanen E, Marks MI: Placebocontrolled double-blind evaluation of trimethoprimsulfamethoxazole treatment of Yersinia enterocolitica gastroenteritis. J Pediatrics 1984, 104:308\u2013311.","journal-title":"J Pediatrics"},{"key":"44_CR48","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1136\/bmj.301.6764.1299","volume":"301","author":"A Fryden","year":"1990","unstructured":"Fryden A, Bengtsson A, Foberg U, et al.: Early antibiotic treatment of reactive arthritis associated with enteric infections: clinical and serological study. BMJ 1990, 301:1299\u20131302.","journal-title":"BMJ"},{"key":"44_CR49","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1093\/jac\/27.6.851","volume":"27","author":"J McLauchlin","year":"1991","unstructured":"McLauchlin J, Audurier A, Taylor AG: Treatment failure and recurrent human listeriosis. J Antimicrobial Chemo 1991, 27:851\u2013857. The analysis focused on documented treatment failures of listeriosis. A consistent finding was that most of these cases either had received short-course therapy or monotherapy with a nonbactericidal combination of antibiotics.","journal-title":"J Antimicrobial Chemo"},{"key":"44_CR50","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1093\/infdis\/172.1.277","volume":"172","author":"E Charpentier","year":"1995","unstructured":"Charpentier E, Gerbaud G, Jacquet C, et al.: Incidence of antibiotic resistance in Listeria species. J Infect Dis 1995, 172:277\u2013281.","journal-title":"J Infect Dis"},{"key":"44_CR51","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1136\/ewjm.172.6.409","volume":"172","author":"G Bruyn De","year":"2000","unstructured":"De Bruyn, G. Infectious Disease: diarrhea. West J Med 2000, 172:409\u2013412.","journal-title":"West J Med"},{"key":"44_CR52","doi-asserted-by":"crossref","first-page":"202","DOI":"10.7326\/0003-4819-117-3-202","volume":"117","author":"J Wistrom","year":"1992","unstructured":"Wistrom J, Jertborn M, Ekwall E, et al.: Empiric treatment of acute diarrheal disease with norfloxacin. Ann Int Med 1992, 117:202\u2013208.","journal-title":"Ann Int Med"},{"key":"44_CR53","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1086\/314995","volume":"180","author":"JC Mohle-Boetani","year":"1999","unstructured":"Mohle-Boetani JC, Reporter R, Werner SB, et al.: An outbreak of Salmonella serogroup Saphra due to cantaloupes from Mexico. J Infect Dis 1999, 180:1361\u20131364.","journal-title":"J Infect Dis"},{"key":"44_CR54","unstructured":"Keene WE, Gill CJ, Farrar JA, et al.: Outbreak suggests seed disinfection may reduce the risk of sproutassociated salmonellosis [abstract]. In International Conference on Emerging Infectious Diseases: ICEID 2000. Atlanta, GA, American Society for Microbiology, July 16\u201319, 2000."}],"container-title":["Current Treatment Options in Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11938-001-0044-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11938-001-0044-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11938-001-0044-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T00:56:55Z","timestamp":1559437015000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11938-001-0044-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,2]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2001,2]]}},"alternative-id":["44"],"URL":"https:\/\/doi.org\/10.1007\/s11938-001-0044-0","relation":{},"ISSN":["1092-8472","1534-309X"],"issn-type":[{"value":"1092-8472","type":"print"},{"value":"1534-309X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,2]]}}}